The effect of colistin resistance-associated mutations on the fitness of Acinetobacter baumannii

Frontiers in Microbiology

Volumn 7, Issue NOV, 2016, Pages

  Mu, Xinli ^a   Wang, Nanfei ^a   Li, Xi ^a   Shi, Keren ^a   Zhou, Zhihui ^a   Yu, Yunsong ^a,b   Hua, Xiaoting ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Colistin; Fitness cost; Resistance mechanism; Whole genome sequencing

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; COLISTIN; LIPOPOLYSACCHARIDE; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; DNA EXTRACTION; DNA SEQUENCE; GEL ELECTROPHORESIS; GENE MUTATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; SANGER SEQUENCING; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; WHOLE GENOME SEQUENCING;

EID: 85006820983     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01715     Document Type: Article

References (31)

1. Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., et al. (2009). Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53, 3628-3634. doi: 10.1128/AAC.00284-09.
2. Andersson, D. I., and Hughes, D. (2010). Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260-271. doi: 10.1038/nrmicro2319.
3. Baker, S., Duy, P. T., Nga, T. V., Dung, T. T., Phat, V. V., Chau, T. T., et al. (2013). Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. Elife 2:e01229. doi: 10.7554/eLife.01229.
4. Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., et al. (2011). Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55, 3370-3379. doi: 10.1128/AAC.00079-11.
5. Beceiro, A., Moreno, A., Fernandez, N., Vallejo, J. A., Aranda, J., Adler, B., et al. (2014). Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob. Agents Chemother. 58, 518-526. doi: 10.1128/AAC.01597-13.
6. Clinical and Laboratory Standards Institute (2014). Performance Standards for Antimicrobial Susceptibility Testing: 24th Informational Supplement. CLSI Document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Deatherage, D. E., and Barrick, J. E. (2014). Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165-188. doi: 10.1007/978-1-4939-0554-6_12.
8. Durante-Mangoni, E., Del Franco, M., Andini, R., Bernardo, M., Giannouli, M., and Zarrilli, R. (2015). Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 82, 222-226. doi: 10.1016/j.diagmicrobio.2015.03.013.
9. Durante-Mangoni, E., Utili, R., and Zarrilli, R. (2014). Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol. 9, 773-789. doi: 10.2217/fmb.14.34.
10. European Committee on Antimicrobial Susceptibility Testing (2015). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 2.0. EUCAST; 2012. Basel: European Committee on Antimicrobial Susceptibility Testing.
11. Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P., and Michalopoulos, A. (2005). Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis. 5:24. doi: 10.1186/1471-2334-5-24.
12. Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y., and ReAct-Action on Antibiotic, Resistance. (2008). Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52, 813-821. doi: 10.1128/AAC.01169-07.
13. Hauser, R., Pech, M., Kijek, J., Yamamoto, H., Titz, B., Naeve, F., et al. (2012). RsfA (YbeB) proteins are conserved ribosomal silencing factors. PLoS Genet. 8:e1002815. doi: 10.1371/journal.pgen.1002815.
14. Hua, X., Zhou, H., Jiang, Y., Feng, Y., Chen, Q., Ruan, Z., et al. (2012). Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline. J. Bacteriol. 194, 6979-6980. doi: 10.1128/JB.01887-12.
15. Jacobs, A. C., Blanchard, C. E., Catherman, S. C., Dunman, P. M., and Murata, Y. (2014). An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization. PLoS ONE 9:e85729. doi: 10.1371/journal.pone.0085729.
16. Li, X., Liu, L., Ji, J., Chen, Q., Hua, X., Jiang, Y., et al. (2015). Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase. Eur. J. Clin. Microbiol. Infect. Dis. 34, 625-631. doi: 10.1007/s10096-014-2272-y.
17. Lopez-Rojas, R., Dominguez-Herrera, J., McConnell, M. J., Docobo-Perez, F., Smani, Y., Fernandez-Reyes, M., et al. (2011a). Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J. Infect. Dis. 203, 545-548. doi: 10.1093/infdis/jiq086.
18. Lopez-Rojas, R., Jimenez-Mejias, M. E., Lepe, J. A., and Pachon, J. (2011b). Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J. Infect. Dis. 204, 1147-1148. doi: 10.1093/infdis/jir476.
19. Lynch, S. V., Dixon, L., Benoit, M. R., Brodie, E. L., Keyhan, M., Hu, P., et al. (2007). Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob. Agents Chemother. 51, 3650-3658. doi: 10.1128/AAC.00601-07.
20. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x.
21. Marcusson, L. L., Frimodt-Moller, N., and Hughes, D. (2009). Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 5:e1000541. doi: 10.1371/journal.ppat.1000541.
22. Marshall, J. M., and Gunn, J. S. (2015). The O-antigen capsule of Salmonella enterica Serovar Typhimurium facilitates serum resistance and surface expression of FliC. Infect. Immun. 83, 3946-3959. doi: 10.1128/IAI.00634-15.
23. Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D., Vinogradov, E., Seemann, T., et al. (2010). Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971-4977. doi: 10.1128/AAC.00834-10.
24. Moffatt, J. H., Harper, M., Mansell, A., Crane, B., Fitzsimons, T. C., Nation, R. L., et al. (2013). Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37. Infect. Immun. 81, 684-689. doi: 10.1128/iai.01362-12.
25. Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656. doi: 10.1128/MMBR.67.4.593-656.2003.
26. Olaitan, A. O., Morand, S., and Rolain, J. M. (2014). Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5:643. doi: 10.3389/fmicb.2014.00643.
27. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582. doi: 10.1128/CMR.00058-07.
28. R Development Core Team (2015). R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing.
29. Thi Khanh Nhu, N., Riordan, D. W., Do Hoang Nhu, T., Thanh, D. P., Thwaites, G., et al. (2016). The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications. Sci Rep. 6:28291. doi: 10.1038/srep28291.
30. Trindade, S., Sousa, A., Xavier, K. B., Dionisio, F., Ferreira, M. G., and Gordo, I. (2009). Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 5:e1000578. doi: 10.1371/journal.pgen.1000578.
31. Wand, M. E., Bock, L. J., Bonney, L. C., and Sutton, J. M. (2015). Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. J. Antimicrob. Chemother. 70, 2209-2216. doi: 10.1093/jac/dkv097.